新型冠状病毒受体ACE2与心血管疾病关系研究的进展  

Research progress of relationship between novel coronavirus receptor ACE2 and cardiovascular disease

作　　者：牟红圆 赵鑫博 盛力[1] MU Hong-yuan;ZHAO Xin-bo;SHENG Li(Department of Cardiology,First Affiliated Hospital of Harbin Medical University,Harbin,Heilongjiang,150081,China)

机构地区：[1]哈尔滨医科大学附属第一医院心血管内科,黑龙江哈尔滨150081

出　　处：《心血管康复医学杂志》2022年第1期107-111,共5页Chinese Journal of Cardiovascular Rehabilitation Medicine

摘　　要：2019冠状病毒病(COVID-19)暴发是国际关注的突发公共卫生事件,COVID-19常导致严重的呼吸衰竭,部分患者会出现急性心肌损伤和高血压等心血管疾病,且COVID-19与病毒受体血管紧张素转换酶2(ACE2)密切相关。本文就COVID-19相关心血管疾病发病率、ACE2介导的相关作用机制及最新的诊治方法作一综述。Outbreak of coronavirus disease 2019(COVID-19)is a public health emergency of international concern.COVID-19 often leads to severe respiratory failure,and some patients will develop cardiovascular diseases such as acute myocardial injury and hypertension.Receptor angiotensin-converting enzyme 2(ACE2)is closely related.The present article makes a review on incidence rate of COVID-19 related cardiovascular disease,related mechanism of action mediated by ACE2 and latest diagnosis and treatment methods.

关 键 词：心血管疾病 冠状病毒感染 肽基二肽酶A 

分 类 号：R541.1[医药卫生—心血管疾病]